The global market for radiopharmaceuticals is projected to reach $14.3 billion by 2030, growing at a CAGR of 10.8% from 2022 to 2030. This report provides insights into the historical performance, current status, and future projections of radioisotopes used in various applications such as oncology, cardiology, endocrine tumors, and neurology. The SPECT radioisotopes segment is expected to achieve a remarkable 10.4% CAGR, while the PET radioisotopes segment is projected to grow at a strong 9.8% CAGR. The U.S. market is estimated to reach $3.1 billion in 2022, while China is forecasted to reach approximately $1.2 billion by 2030 with a CAGR of 13.9%. The report also provides insights into the competitive landscape of the market.
Thu, 12 Oct 2023 14:31:00 GMT | Business Wire